Orosco-Ttamina, A.L.; Arana Yi, C.; Tsang, M.; Hilal, T.; Rosenthal, A.; Munoz, J.
Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access. Cancers 2025, 17, 3216.
https://doi.org/10.3390/cancers17193216
AMA Style
Orosco-Ttamina AL, Arana Yi C, Tsang M, Hilal T, Rosenthal A, Munoz J.
Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access. Cancers. 2025; 17(19):3216.
https://doi.org/10.3390/cancers17193216
Chicago/Turabian Style
Orosco-Ttamina, Angel Luis, Cecilia Arana Yi, Mazie Tsang, Talal Hilal, Allison Rosenthal, and Javier Munoz.
2025. "Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access" Cancers 17, no. 19: 3216.
https://doi.org/10.3390/cancers17193216
APA Style
Orosco-Ttamina, A. L., Arana Yi, C., Tsang, M., Hilal, T., Rosenthal, A., & Munoz, J.
(2025). Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access. Cancers, 17(19), 3216.
https://doi.org/10.3390/cancers17193216